LYEL Lyell Immunopharma, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 5, 2026 10-K/10-Q 八月 6, 2026
$8.86
· % 处于52周区间
· 高于低点
· 至高点
$8.8252周低点
$40.1152周高点
市值 (MRQ)
$207M
P/E (TTM)
-0.6
EPS (TTM)
$-16.01
收入 (TTM)
$27.0K
LYEL 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$8.86
市值 (MRQ)
$207M
P/E (TTM)
-0.6
EPS (TTM)
$-16.01
收入 (TTM)
$27.0K
ROE (TTM)
-93.3%
52周区间
$9–$40
LYEL 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2025年6月2日 | 1-for-20 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$36.0K2019-12-31 → 2025-12-31
EPS$-16.062019-12-31 → 2025-12-31
自由现金流$-151M2021-12-31 → 2025-12-31
净利率-920285.2%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | LYEL | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -0.65年均值 ≈-36.5 | ≈-36.5 | · | · | |
| P/S (TTM) | 7673.35年均值 ≈31914.9 | ≈31914.9 | 14.6 | 估值过高 | |
| 市净率 (MRQ) | 0.95年均值 ≈17.7 | ≈17.7 | 2.9 | 低估 | |
| 股价/自由现金流 (TTM) | -1.55年均值 ≈-74.4 | ≈-74.4 | · | · | |
| 市现率 (TTM) | -1.65年均值 ≈-97.5 | ≈-97.5 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 0.85年均值 ≈17.7 | ≈17.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | LYEL | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -949981.5%5年均值 ≈-305742.2% | ≈-305742.2% | -752.1% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | -914733.3%5年均值 ≈-289750.0% | ≈-289750.0% | -752.1% | 弱 | |
| 净利润率 (TTM) | -920285.2%5年均值 ≈-301538.5% | ≈-301538.5% | -1884.8% | 弱 | |
| ROA (TTM) | -71.3%5年均值 ≈-38.3% | ≈-38.3% | -27.3% | 弱 | |
| ROE (TTM) | -93.3%5年均值 ≈-51.7% | ≈-51.7% | -31.2% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | LYEL | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 5.45年均值 ≈11.9 | ≈11.9 | 8.4 | 低流动性 | |
| Quick Ratio (速动比率) | 5.05年均值 ≈11.6 | ≈11.6 | 5.3 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | LYEL | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -41.0%5年均值 ≈107.7% | ≈107.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -92.5%5年均值 ≈-83.0% | ≈-83.0% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -65.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | LYEL | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.3 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$223.60 | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-20.5%
下次报告
十一月 09, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 10, 2026 | $-1.92 | $-2.06 | 6.7% |
| 2026年3月31日 | 五月 11, 2026 | $-1.10 | $-2.41 | 54.4% |
| 2025年12月31日 | $-7.50 | $-2.28 | -229.5% | |
| 2025年9月30日 | $-2.13 | $-2.70 | 21.0% | |
| 2025年6月30日 | $-2.89 | $-3.65 | 20.9% | |
| 2025年3月31日 | $-3.54 | $-3.67 | 3.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $36.0K | $61.0K | $130.0K | $85M | $11M | $8M | |
| R&D Expense | · | · | $183M | $159M | $139M | $182M | |
| SG&A Expense | $45M | $52M | $67M | $117M | $89M | $47M | |
| Operating Expenses | $269M | $359M | $247M | $272M | $225M | $220M | |
| Operating Income | $-269M | $-359M | $-247M | $-187M | $-215M | $-212M | |
| Other Non-op | $-18M | $5M | $2M | $2M | $-161.0K | $2M | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-274M | $-343M | $-235M | $-183M | $-250M | $-204M | |
| EPS (Basic) | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 | $-15.69 | |
| EPS (Diluted) | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 | $-15.69 | |
| Shares (Basic) | 17,093,000 | 13,074,000 | 12,549,000 | 247,080,000 | 135,918,000 | 13,258,000 | |
| Shares (Diluted) | 17,093,000 | 13,074,000 | 12,549,000 | 247,080,000 | 135,918,000 | 13,258,000 | |
| EBITDA | $-258M | $-339M | $-227M | $-169M | $-201M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $106M | $146M | $124M | $294M | $140M | |
| Short-term Investments | $187M | $265M | $401M | $517M | $321M | $472M | |
| Prepaid Expense | $14M | $9M | $8M | $11M | $11M | $5M | |
| Current Assets | $261M | $380M | $555M | $651M | $626M | $618M | |
| PP&E (Net) | $35M | $48M | $103M | $123M | $120M | $77M | |
| PP&E (Gross) | $109M | $119M | $154M | $155M | $135M | $82M | |
| Accum. Depreciation | $74M | $71M | $52M | $32M | $15M | $5M | |
| Other Non-current Assets | $5M | $5M | $4M | $5M | $3M | $3M | |
| Total Assets | $340M | $491M | $750M | $938M | $1.13B | $908M | |
| Accounts Payable | $3M | $5M | $5M | $4M | $3M | $9M | |
| Current Liabilities | $49M | $54M | $35M | $37M | $47M | $49M | |
| Capital Leases | $42M | $51M | $57M | $63M | $67M | $51M | |
| Other Non-current Liabilities | $517.0K | $3M | $4M | $4M | $5M | $532.0K | |
| Total Liabilities | $92M | $108M | $95M | $104M | $198M | $190M | |
| Common Stock | $2.0K | $1.0K | $25.0K | $25.0K | $24.0K | $2.0K | |
| Paid-in Capital | $1.87B | $1.73B | $1.66B | $1.61B | $1.52B | $41M | |
| Retained Earnings | $-1.62B | $-1.35B | $-1.00B | $-767M | $-584M | $-334M | |
| AOCI | $242.0K | $291.0K | $-94.0K | $-8M | $-2M | $256.0K | |
| Stockholders' Equity | $248M | $383M | $655M | $833M | $930M | $-293M | |
| Liabilities + Equity | $340M | $491M | $750M | $938M | $1.13B | $908M | |
| Shares Outstanding | 21,251,000 | 14,744,000 | 12,698,000 | 12,479,000 | 242,738,000 | 15,570,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $12M | $20M | $20M | $18M | $14M | $4M | |
| Stock-based Comp | $42M | $33M | $47M | $82M | $62M | $33M | |
| Restructuring | · | · | $6M | · | · | · | |
| Other Non-cash | $71M | $128M | $4M | $-86M | $48M | · | |
| Operating Cash Flow | $-150M | $-162M | $-164M | $-170M | $-126M | $-161M | |
| CapEx | $780.0K | $464.0K | $3M | $24M | $66M | $51M | |
| Investing Cash Flow | $54M | $122M | $184M | $-12M | $-122M | $-274M | |
| Stock Issued | $50M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | $0 | $0 | $12M | |
| Net Stock Activity | $50M | · | · | $0 | $0 | · | |
| Financing Cash Flow | $50M | $1M | $2M | $11M | $401M | $477M | |
| Net Change in Cash | $-46M | $-39M | $22M | $-170M | $153M | $42M | |
| Free Cash Flow | $-151M | $-163M | $-166M | $-194M | $-192M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -748344.4% | -588123.0% | -190006.1% | -220.9% | -2016.7% | · | |
| Net Margin | -762355.6% | -562285.2% | -180486.1% | -216.2% | -2349.5% | · | |
| EBITDA Margin | -716291.7% | -555941.0% | -174429.2% | -199.6% | -1888.8% | · | |
| ROA | -66.1% | -55.3% | -27.8% | -17.7% | -24.6% | · | |
| ROE | -100.3% | -75.1% | -34.7% | -22.1% | -26.1% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 7.1 | 16.1 | 17.6 | 13.4 | · | |
| Quick Ratio | 5.0 | 6.9 | 15.8 | 17.3 | 13.2 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.68 | $1.30 | $2.58 | $3.34 | $3.83 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.34 | $78.36 | · | |
| Cash Flow / Share | $-8.78 | $-0.62 | $-0.65 | $-0.69 | $-928.86 | · | |
| Cash / Share | $2.83 | $0.36 | $0.57 | $0.50 | $1.21 | · | |
| EPS (TTM) | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -41.0% | -53.1% | -99.9% | 695.1% | 37.3% | · | |
| Revenue CAGR 3Y | -92.5% | -82.1% | -74.4% | · | · | · | |
| Revenue CAGR 5Y | -65.8% | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $36.0K | $61.0K | $130.0K | $85M | $11M | · | |
| Net Income TTM | $-274M | $-343M | $-235M | $-183M | $-250M | · | |
| Market Cap | $654M | $3.77B | $9.85B | $17.32B | $37.58B | · | |
| P/E | -1.9 | -0.5 | -2.1 | -93.8 | -84.1 | · | |
| P/S | 18169.6 | 61875.6 | 75796.7 | 204.5 | 3528.2 | · | |
| P/B | 2.6 | 9.9 | 15.0 | 20.8 | 40.4 | · | |
| P / Tangible Book | 2.6 | 9.9 | 15.0 | 20.8 | 40.4 | · | |
| P / Cash Flow | -4.4 | -23.2 | -60.2 | -102.1 | -297.6 | · | |
| P / FCF | -4.3 | -23.2 | -59.2 | -89.4 | -196.0 | · | |
| Earnings Yield | -52.2% | -204.9% | -48.2% | -1.1% | -1.2% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0K | $2.0K | $6.0K | $15.0K | $8.0K | $7.0K | $11.0K | $34.0K | $13.0K | $3.0K | $25.0K | $27.0K | $65.0K | $3.0K | $36M | $553.0K | |
| R&D Expense | $40M | $37M | · | $28M | $35M | $43M | · | $40M | $40M | $43M | $44M | $47M | $45M | $42M | $44M | $36M | |
| SG&A Expense | $10M | $10M | $11M | $11M | $10M | $14M | $15M | $12M | $12M | $13M | $16M | $19M | $19M | $26M | $30M | $34M | |
| Operating Expenses | $47M | $44M | $128M | $37M | $47M | $57M | $201M | $51M | $52M | $56M | $59M | $66M | $63M | $66M | $73M | $69M | |
| Operating Income | $-47M | $-44M | $-128M | $-37M | $-47M | $-57M | $-201M | $-51M | $-52M | $-56M | $-59M | $-66M | $-63M | $-66M | $-37M | $-69M | |
| Other Non-op | $398.0K | $18M | $-16M | $-5M | $1M | $1M | $4M | $-43.0K | $-645.0K | $1M | $2M | $-326.0K | $1M | $-1M | $-14.0K | $35.0K | |
| Net Income | $-45M | $-24M | $-141M | $-39M | $-43M | $-52M | $-192M | $-45M | $-46M | $-61M | $-51M | $-64M | $-67M | $-70M | $-36M | $-68M | |
| EPS (Basic) | $-1.92 | $-1.10 | $-10.86 | $-2.13 | $-2.89 | $-3.54 | $-18.92 | $-3.48 | $-3.59 | $-0.24 | $-0.20 | $-0.26 | $-0.27 | $-0.28 | $-0.15 | $-0.28 | |
| EPS (Diluted) | $-1.92 | $-1.10 | $-10.86 | $-2.13 | $-2.89 | $-3.54 | $-18.92 | $-3.48 | $-3.59 | $-0.24 | $-0.20 | $-0.26 | $-0.27 | $-0.28 | $-0.15 | $-0.28 | |
| Shares (Basic) | 23,364,000 | 21,876,000 | · | 18,268,000 | 14,793,000 | 14,755,000 | · | 12,815,000 | 12,770,000 | 254,252,000 | 251,318,000 | 250,204,000 | 249,591,000 | 248,320,000 | 246,312,000 | 244,178,000 | |
| Shares (Diluted) | 23,364,000 | 21,876,000 | · | 18,268,000 | 14,793,000 | 14,755,000 | · | 12,815,000 | 12,770,000 | 254,252,000 | 251,318,000 | 250,204,000 | 249,591,000 | 248,320,000 | 246,312,000 | 244,178,000 | |
| EBITDA | $-47M | $-42M | · | $-37M | $-47M | $-54M | · | $-51M | · | $-51M | $-59M | $-66M | $-58M | $-66M | $-37M | $-64M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $73M | $91M | $60M | $124M | $99M | $120M | $106M | $100M | $133M | $126M | $286M | $224M | $109M | $116M | $206M | $223M | |
| Short-term Investments | $131M | $163M | $187M | $196M | $178M | $181M | $265M | $340M | $358M | $401M | $289M | $371M | $503M | $532M | $450M | $391M | |
| Prepaid Expense | $9M | $13M | $14M | $9M | $5M | $8M | $9M | $9M | $9M | $8M | $11M | $11M | $12M | $12M | $11M | $12M | |
| Current Assets | $214M | $267M | $261M | $328M | $282M | $309M | $380M | $450M | $500M | $534M | $587M | $606M | $624M | $660M | $667M | $626M | |
| PP&E (Net) | $31M | $33M | $35M | $37M | $39M | $44M | $48M | $88M | $93M | $98M | $108M | $114M | $119M | $126M | $128M | $126M | |
| PP&E (Gross) | · | · | $109M | · | · | · | $119M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $74M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $6M | $5M | $5M | $3M | $3M | $3M | $5M | $5M | $4M | $4M | $4M | $5M | $5M | $3M | $4M | $4M | |
| Total Assets | $311M | $351M | $340M | $408M | $385M | $430M | $491M | $619M | $654M | $694M | $795M | $835M | $880M | $977M | $1.02B | $1.07B | |
| Accounts Payable | $4M | $5M | $3M | $3M | $3M | $4M | $5M | $4M | $4M | $5M | $4M | $6M | $6M | $5M | $4M | $7M | |
| Current Liabilities | $40M | $37M | $49M | $32M | $37M | $41M | $54M | $34M | $31M | $32M | $35M | $34M | $31M | $51M | $50M | $41M | |
| Capital Leases | $37M | $39M | $42M | $44M | $47M | $49M | $51M | $51M | $53M | $55M | $59M | $60M | $62M | $65M | $66M | $67M | |
| Other Non-current Liabilities | $537.0K | $527.0K | $517.0K | $3M | $3M | $3M | $3M | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $77M | $77M | $92M | $79M | $87M | $93M | $108M | $89M | $88M | $91M | $97M | $98M | $97M | $157M | $154M | $191M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $30.0K | $1.0K | $26.0K | $26.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| Paid-in Capital | $1.92B | $1.92B | $1.87B | $1.81B | $1.74B | $1.73B | $1.73B | $1.68B | $1.68B | $1.67B | $1.65B | $1.64B | $1.62B | $1.59B | $1.57B | $1.54B | |
| Retained Earnings | $-1.69B | $-1.64B | $-1.62B | $-1.48B | $-1.44B | $-1.40B | $-1.35B | $-1.15B | $-1.11B | $-1.06B | $-949M | $-898M | $-834M | $-759M | $-689M | $-653M | |
| AOCI | $-158.0K | $-9.0K | $242.0K | $201.0K | $57.0K | $158.0K | $291.0K | $760.0K | $-397.0K | $-404.0K | $-1M | $-2M | $-4M | $-10M | $-8M | $-7M | |
| Stockholders' Equity | $234M | $274M | $248M | $329M | $299M | $337M | $383M | $531M | $567M | $603M | $698M | $737M | $784M | $820M | $868M | $881M | |
| Liabilities + Equity | $311M | $351M | $340M | $408M | $385M | $430M | $491M | $619M | $654M | $694M | $795M | $835M | $880M | $977M | $1.02B | $1.07B | |
| Shares Outstanding | 23,397,000 | 23,328,000 | 21,251,000 | 19,294,000 | 14,831,000 | 295,284,000 | 14,744,000 | 256,564,000 | 255,948,000 | 254,927,000 | 251,869,000 | 251,027,000 | 249,609,000 | 249,240,000 | 247,110,000 | 245,423,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | |
| Stock-based Comp | $5M | $4M | $26M | $5M | $5M | $6M | $8M | $8M | $8M | $9M | $11M | $14M | $14M | $19M | $22M | $22M | |
| Other Non-cash | · | $-21M | · | · | · | $-12M | · | · | · | $4M | · | · | $2M | · | · | $-6M | |
| Operating Cash Flow | $-34M | $-39M | $-32M | $-29M | $-34M | $-55M | $-47M | $-35M | $-38M | $-42M | $-38M | $-39M | $-46M | $-37M | $-44M | $-48M | |
| CapEx | $256.0K | $89.0K | $304.0K | $62.0K | $168.0K | $246.0K | $44.0K | $59.0K | $331.0K | $30.0K | $195.0K | $933.0K | $2M | $3M | $7M | $10M | |
| Investing Cash Flow | $16M | $17M | $-31M | $3M | $13M | $69M | $54M | $2M | $45M | $22M | $100M | $153M | $32M | $-57M | $25M | $-26M | |
| Stock Issued | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $522.0K | $52M | $222.0K | $50M | $183.0K | $1.0K | $437.0K | $0 | $862.0K | $27.0K | $-143.0K | $1M | $-69.0K | $5M | $2M | $3M | |
| Net Change in Cash | $-18M | $31M | $-63M | $25M | $-22M | $15M | $7M | $-33M | $8M | $-20M | $62M | $115M | $-14M | $-89M | $-17M | $-71M | |
| Free Cash Flow | · | $-39M | · | · | · | $-55M | · | · | · | $-42M | · | · | $-48M | · | · | $-58M |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1183425.0% | -2213050.0% | · | -248353.3% | -589250.0% | -819528.6% | · | -148544.1% | · | -1852500.0% | -236156.0% | -244092.6% | -96240.0% | -2214566.7% | -104.2% | -12400.7% | |
| Net Margin | -1118875.0% | -1207650.0% | · | -258973.3% | -533550.0% | -745642.9% | · | -131126.5% | · | -2022233.3% | -203412.0% | -236629.6% | -103013.9% | -2341800.0% | -101.6% | -12322.6% | |
| EBITDA Margin | -1183425.0% | -2096450.0% | · | -248353.3% | -589250.0% | -770371.4% | · | -148544.1% | · | -1685033.3% | -236156.0% | -244092.6% | -88506.2% | -2214566.7% | -104.2% | -11643.6% | |
| ROA | -12.8% | -6.2% | · | -7.6% | -8.2% | -9.3% | · | -6.3% | · | -7.7% | -5.7% | -6.9% | -6.9% | -6.5% | -3.2% | -12.7% | |
| ROE | -16.8% | -7.9% | · | -9.0% | -9.9% | -11.1% | · | -7.3% | · | -8.8% | -6.7% | -8.0% | -8.0% | -7.8% | -3.8% | -15.5% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 7.2 | · | 10.3 | 7.6 | 7.5 | · | 13.4 | · | 16.5 | 16.7 | 17.6 | 20.3 | 12.9 | 13.3 | 15.2 | |
| Quick Ratio | 5.1 | 6.9 | · | 10.0 | 7.5 | 7.3 | · | 13.1 | · | 16.3 | 16.4 | 17.3 | 19.9 | 12.7 | 13.0 | 15.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.99 | $11.73 | · | $17.06 | $20.16 | $1.14 | · | $2.07 | · | $2.37 | $2.77 | $2.94 | $3.14 | $3.29 | $3.51 | $3.59 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.00 | |
| Cash Flow / Share | · | $-1.76 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | $-0.19 | · | · | $-0.20 | |
| Cash / Share | $3.12 | $3.89 | · | $6.40 | $6.66 | $0.41 | · | $0.39 | · | $0.49 | $1.14 | $0.89 | $0.44 | $0.47 | $0.83 | $0.91 | |
| EPS (TTM) | $-16.01 | $-16.98 | · | $-27.48 | $-28.83 | $-29.53 | · | $-25.28 | $-22.00 | $-18.67 | $-0.76 | $-0.84 | $-0.73 | $2.31 | $2.39 | $1.07 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $27.0K | $31.0K | · | $41.0K | $60.0K | $65.0K | · | $63.0K | $54.0K | $68.0K | $49M | $48M | $84M | $39M | $42M | $9M | |
| Net Income TTM | $-248M | $-246M | · | $-326M | $-331M | $-335M | · | $-204M | $-210M | $-228M | $-190M | $-210M | $-182M | $-258M | $-237M | $-263M | |
| Market Cap | $329M | $468M | · | $313M | $131M | $3.18B | · | $7.08B | · | $11.37B | $7.40B | $15.97B | $11.78B | $36.54B | $32.22B | $24.79B | |
| P/E | -0.9 | -1.2 | · | -0.6 | -0.3 | -0.4 | · | -1.1 | -1.3 | -2.4 | -38.7 | -75.7 | -64.7 | 63.5 | 54.6 | 94.4 | |
| P/S | 12175.1 | 15095.5 | · | 7642.3 | 2185.1 | 48880.9 | · | 112399.5 | · | 167202.1 | 152.7 | 329.3 | 139.9 | 934.0 | 769.6 | 2830.3 | |
| P/B | 1.4 | 1.7 | · | 1.0 | 0.4 | 9.4 | · | 13.3 | · | 18.9 | 10.6 | 21.7 | 15.0 | 44.6 | 37.1 | 28.1 | |
| P / Tangible Book | 1.4 | 1.7 | · | 1.0 | 0.4 | 9.4 | · | 13.3 | 13.1 | 18.9 | 10.6 | 21.7 | 15.0 | 44.6 | 37.1 | 28.1 | |
| P / Cash Flow | · | -12.2 | · | · | · | -58.0 | · | · | · | -270.6 | · | · | -254.9 | · | · | -518.0 | |
| Earnings Yield | -113.9% | -84.7% | · | -169.2% | -326.1% | -274.4% | · | -91.6% | -75.9% | -41.9% | -2.6% | -1.3% | -1.6% | 1.6% | 1.8% | 1.1% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $36.0K | $61.0K | $130.0K | $85M | $11M |
| 营业利润率 % | -748344.4% | -588123.0% | -190006.1% | -220.9% | -2016.7% |
| 净收入 | $-274M | $-343M | $-235M | $-183M | $-250M |
| 稀释后每股收益 (EPS) | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 5.3 | 7.1 | 16.1 | 17.6 | 13.4 |
| 速动比率 | 5.0 | 6.9 | 15.8 | 17.3 | 13.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-151M | $-163M | $-166M | $-194M | $-192M |
机构持有人 (13F) 95 家申报者 · $240.0M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
95
持有价值
$240.0M
新仓位
26
已退出持仓
9
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 26 (+6 与上一季度对比) | 9 (+3 与上一季度对比) | 29 (+4 与上一季度对比) | 19 (+11 与上一季度对比) | +67K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| ARCH Venture Management, LLC | $45525211 | 3247162 | 18.97% | 股份 |
| MWG Caph Ltd | $31029810 | 1008116 | 12.93% | 股份 |
| VANGUARD GROUP INC | $25437516 | 826430 | 10.60% | 股份 |
| GSK plc | $21252859 | 1512659 | 8.86% | 股份 |
| MWG Management Ltd. | $16371804 | 1008116 | 6.82% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $11054175 | 786774 | 4.61% | 股份 |
| Orland Properties Ltd | $10603507 | 754698 | 4.42% | 股份 |
| BlackRock, Inc. | $10177005 | 724342 | 4.24% | 股份 |
| Almitas Capital LLC | $8168768 | 581407 | 3.40% | 股份 |
| Foresite Capital Management V, LLC | $6693223 | 476386 | 2.79% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $5162996 | 367473 | 2.15% | 股份 |
| Opaleye Management Inc. | $4833551 | 344025 | 2.01% | 股份 |
| venBio Partners LLC | $4744643 | 337697 | 1.98% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $4365887 | 310636 | 1.82% | 股份 |
| Alphabet Inc. | $4120247 | 293256 | 1.72% | 股份 |
| STATE STREET CORP | $2603774 | 185322 | 1.08% | 股份 |
| HSG Holding Ltd | $2139801 | 152299 | 0.89% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1829169 | 130190 | 0.76% | 股份 |
| NORTHERN TRUST CORP | $1664925 | 118500 | 0.69% | 股份 |
| Qube Research & Technologies Ltd | $1552961 | 110531 | 0.65% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1511359 | 107570 | 0.63% | 股份 |
| MARSHALL WACE, LLP | $1493516 | 106300 | 0.62% | 股份 |
| Velan Capital Investment Management LP | $1475250 | 105000 | 0.61% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1307985 | 93095 | 0.54% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1291069 | 91891 | 0.54% | 股份 |
| MIC Capital Management UK LLP | $1222743 | 87028 | 0.51% | 股份 |
| GOLDMAN SACHS GROUP INC | $1219245 | 86779 | 0.51% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $957066 | 68315 | 0.40% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $743624 | 52927 | 0.31% | 股份 |
| JANE STREET GROUP, LLC | $646455 | 46011 | 0.27% | 股份 |
| Squarepoint Ops LLC | $594624 | 42322 | 0.25% | 股份 |
| Ikarian Capital, LLC | $577188 | 41081 | 0.24% | 股份 |
| MORGAN STANLEY | $520553 | 37050 | 0.22% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $413225 | 29411 | 0.17% | 股份 |
| Point72 Asset Management, L.P. | $366424 | 26080 | 0.15% | 股份 |
| UBS Group AG | $365048 | 25982 | 0.15% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $363895 | 25900 | 0.15% | 买入期权 |
| Bank of New York Mellon Corp | $346656 | 24673 | 0.14% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $344787 | 24540 | 0.14% | 股份 |
| Jump Financial, LLC | $308482 | 21956 | 0.13% | 股份 |
| Clearstead Advisors, LLC | $280410 | 19958 | 0.12% | 股份 |
| EntryPoint Capital, LLC | $272710 | 19410 | 0.11% | 股份 |
| CITADEL ADVISORS LLC | $262665 | 18695 | 0.11% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $252900 | 18000 | 0.11% | 股份 |
| CITADEL ADVISORS LLC | $251495 | 17900 | 0.10% | 卖出期权 |
| Susquehanna Portfolio Strategies, LLC | $251144 | 17875 | 0.10% | 股份 |
| CITADEL ADVISORS LLC | $238850 | 17000 | 0.10% | 买入期权 |
| Allspring Global Investments Holdings, LLC | $226837 | 16145 | 0.09% | 股份 |
| RHUMBLINE ADVISERS | $217234 | 15462 | 0.09% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $199510 | 14200 | 0.08% | 卖出期权 |
公司内部人士 25 位内幕人士 · 14 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Lynn Seely | President and CEO | 2026年8月21日 S | 63899 | 0 | 6 | $-353079 |
| Elizabeth Homans | Chief Executive Officer | 2022年3月16日 A | · | 0 | 0 | $0 |
| Charles W. Newton | Chief Financial Officer | 2025年8月21日 S | 15306 | 0 | 0 | $0 |
| Stephen J. Hill | Chief Operating Officer | 2026年8月21日 S | 16816 | 0 | 6 | $-51290 |
| Jarrad Mattieu Aguirre | Chief Medical Officer | 2026年9月10日 A | · | 0 | 0 | $0 |
| David Shook | Chief Medical Officer | 2026年9月10日 S | 20423 | 0 | 2 | $-31339 |
| Gary K. Lee | Chief Scientific Officer | 2026年8月21日 S | 16220 | 0 | 6 | $-71695 |
| Veronica Sanchez Bulis | VP, Corporate Controller | 2026年8月10日 S | 14799 | 0 | 6 | $-96909 |
| Smital Shah | Chief Fin. and Bus. Officer | 2026年3月9日 A | · | 0 | 0 | $0 |
| Mark A Meltz | General Counsel | 2026年2月10日 A | · | 0 | 0 | $0 |
| Matthew Lang | Chief Business Officer | 2025年2月10日 A | 162500 | 0 | 0 | $0 |
| Tina M. Albertson | Chief Medical Officer | 2023年2月24日 A | · | 0 | 0 | $0 |
| Rahsaan Thompson | Chief Legal Officer | 2023年2月24日 A | · | 0 | 0 | $0 |
| Heather D Turner | Chief General Counsel | 2022年3月16日 A | · | 0 | 0 | $0 |
| Mark Bachleda | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Elizabeth G Nabel | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Richard Klausner | 董事 | 2026年6月10日 A | 843365 | 0 | 0 | $0 |
| Sumant Ramachandra | 董事 | 2026年6月10日 A | 200000 | 0 | 0 | $0 |
| Cathy Friedman | 董事 | 2026年6月10日 A | 236370 | 0 | 0 | $0 |
| Otis W Brawley | 董事 | 2026年6月10日 A | 35640 | 0 | 0 | $0 |
| William Jl Rieflin | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Hans Edgar Bishop | 董事 | 2024年6月14日 A | 4685614 | 0 | 0 | $0 |
| Robert Nelsen | 董事 | 2024年6月14日 A | 18206358 | 0 | 0 | $0 |
| Innovative Cellular Therapeutics Holdings Ltd | 10% 所有者 | 2026年7月27日 J | 2818980 | 0 | 2 | $-274 |
| GSK plc | · | 2021年6月21日 C | 30253189 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 16 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.03% | 32319 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.01% | 1674 SH | 2026年10月2日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 8183 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.01% | 57662 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.00% | 4474 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.00% | 222823 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 8835 SH | 2026年10月2日 | 每日 |
| DCOR · Dimensional ETF Trust | 0.00% | 1961 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 1736 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 163755 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 604461 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 54398 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1151 SH | 2026年8月19日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 409 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.00% | 28159 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 89130 SH | 2026年9月11日 | 每日 |
LYEL 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$41.50
+368.7%
4 28.6%
强烈买入
8 57.1%
买入
1 7.1%
持有
1 7.1%
卖出
0 0.0%
强烈卖出
12个月价格目标
8 位分析师 · 2026-10-02平均目标 $37.88 +327.7%
← 低于所有目标
当前价格 $8.86
最低$12.00
平均值$37.88
最高$49.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报